NORLIQVA is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Cmp Pharma, Inc.. The primary component is Amlodipine.
Product ID | 46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540 |
NDC | 46287-035 |
Product Type | Human Prescription Drug |
Proprietary Name | NORLIQVA |
Generic Name | Amlodipine |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-04-15 |
Marketing Category | NDA / |
Application Number | NDA214439 |
Labeler Name | CMP Pharma, Inc. |
Substance Name | AMLODIPINE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
46287-035 | NORLIQVA | amlodipine |
33342-015 | Amlodipine | Amlodipine |
33342-016 | Amlodipine | Amlodipine |
0615-6582 | Amlodipine Besylate | Amlodipine |
52652-5001 | Katerzia | Amlodipine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NORLIQVA 90522907 not registered Live/Pending |
CMP Development LLC 2021-02-10 |